Next Article in Journal
Making the Transition from Student to Resident: A Method to Individualize a PGY1 Program
Previous Article in Journal
Perception of the Professional Knowledge of and Education on the Medical Technology Products among the Pharmacists in the Baltic and Nordic Countries—A Cross-Sectional Exploratory Study
Article Menu

Export Article

Open AccessArticle
Pharmacy 2016, 4(4), 30; doi:10.3390/pharmacy4040030

Assessment of Perceived Barriers to Herpes Zoster Vaccination among Geriatric Primary Care Providers

1
Department of Family Medicine and Community Health, University of Minnesota, Minneapolis, MN 55455, USA
2
Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, MN 55455, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Yvonne Perrie
Received: 2 July 2016 / Revised: 21 September 2016 / Accepted: 15 October 2016 / Published: 18 October 2016
View Full-Text   |   Download PDF [182 KB, uploaded 18 October 2016]

Abstract

The herpes zoster vaccine is recommended for use in adults 60 years of age and older to reduce the incidence and morbidity associated with infection. Its limited uptake has been attributed to logistical barriers, but uncertain efficacy and safety in subsets of this patient population could also be contributing. The purpose of this study was to evaluate the current vaccination practices, barriers to vaccination, knowledge of vaccination reimbursement and strategies to evaluate for insurance coverage among an urban, safety net, teaching hospital, geriatric primary care provider group through a survey administered via paper and online platforms. Survey participants (n = 10) reported lack of availability of the vaccine in their practice settings (6/10), with half of providers (5/10) referring patients to outside pharmacies or to other practice settings (2/10) for vaccine administration. Reimbursement issues and storage requirements were perceived as major barriers by 40% (4/10) of providers, whereas 80% (8/10) of providers reported that concerns about safety and effectiveness of the vaccine were not major barriers to vaccination. Logistical barriers, rather than concerns about safety and effectiveness of the vaccine, were reported as major barriers to vaccination by a significant portion of providers. Lack of availability and reimbursement problems for practice sites allow for gaps in care. Partnership with community and long-term care pharmacies could serve as a possible solution. View Full-Text
Keywords: barriers; Herpes zoster; immunization; long-term care; vaccination barriers; Herpes zoster; immunization; long-term care; vaccination
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Montag Schafer, K.; Reidt, S. Assessment of Perceived Barriers to Herpes Zoster Vaccination among Geriatric Primary Care Providers. Pharmacy 2016, 4, 30.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top